Analysis of the success rates of new drug development in Japan and the lag behind the US
Year of publication: |
2012
|
---|---|
Authors: | Hirai, Yuka ; Yamanaka, Yosuke ; Kusama, Makiko ; Ishibashi, Taro ; Sugiyama, Yuichi ; Ono, Shunsuke |
Published in: |
Health Policy. - Elsevier, ISSN 0168-8510. - Vol. 104.2012, 3, p. 241-246
|
Publisher: |
Elsevier |
Subject: | Pharmaceuticals | Research and development | Policy | Japan | Drug industry | Risk management |
-
Global value chains, import orientation, and the state : South Africa's pharmaceutical industry
Horner, Rory, (2022)
-
Bulk drug industry in India : challenges and prospects
James, T. C., (2020)
-
McKelvey, Maureen D., (2016)
- More ...
-
A Japanese view on the next round of agricultural negotiations
Ishibashi, Taro, (2000)
-
Clinical Trials and the New Good Clinical Practice Guideline in Japan: An Economic Perspective
Ono, Shunsuke, (2000)
- More ...